# Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART)

> **NCT06434779** · NA · NOT_YET_RECRUITING · sponsor: **Vascular Science LP GmbH** · enrollment: 200 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** JETi 6F and 8F Thrombectomy system

## Key facts

- **NCT ID:** NCT06434779
- **Lead sponsor:** Vascular Science LP GmbH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-07-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06434779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06434779, "Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06434779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
